Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here:

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Paul Franks

Paul Franks

Principal investigator

Paul Franks

Association analyses based on false discovery rate implicate new loci for coronary artery disease


  • Christopher P Nelson
  • Anuj Goel
  • Adam S Butterworth
  • Stavroula Kanoni
  • Tom R. Webb
  • Eirini Marouli
  • Lingyao Zeng
  • Ioanna Ntalla
  • Florence Y. Lai
  • Jemma C Hopewell
  • Olga Giannakopoulou
  • Tao Jiang
  • Stephen E. Hamby
  • Emanuele Di Angelantonio
  • Themistocles L Assimes
  • Erwin P Bottinger
  • John C Chambers
  • Robert Clarke
  • Colin N. A. Palmer
  • Richard M. Cubbon
  • Patrick T Ellinor
  • Raili Ermel
  • Evangelos Evangelou
  • Paul W. Franks
  • Christopher Grace
  • Dongfeng Gu
  • Aroon D Hingorani
  • Joanna M. M. Howson
  • Erik Ingelsson
  • Adnan Kastrati
  • Thorsten Kessler
  • Theodosios Kyriakou
  • Terho Lehtimäki
  • Xiangfeng Lu
  • Yingchang Lu
  • Winfried März
  • Ruth McPherson
  • Andres Metspalu
  • Mar Pujades-Rodriguez
  • Arno Ruusalepp
  • Eric Schadt
  • Amand F. Schmidt
  • Michael J. Sweeting
  • Pierre A. Zalloua
  • Kamal Alghalayini
  • Bernard D. Keavney
  • Jaspal S Kooner
  • Ruth J F Loos
  • Riyaz S. Patel
  • Martin K. Rutter
  • Maciej Tomaszewski
  • Ioanna Tzoulaki
  • Eleftheria Zeggini
  • Jeanette Erdmann
  • George Dedoussis
  • Johan L M Björkegren
  • Heribert Schunkert
  • Martin Farrall
  • John Danesh
  • Nilesh J. Samani
  • Hugh Watkins
  • Panos Deloukas

Summary, in English

Genome-wide association studies (GWAS) in coronary artery disease (CAD) had identified 66 loci at 'genome-wide significance' (P < 5 × 10 '8) at the time of this analysis, but a much larger number of putative loci at a false discovery rate (FDR) of 5% (refs. 1,2,3,4). Here we leverage an interim release of UK Biobank (UKBB) data to evaluate the validity of the FDR approach. We tested a CAD phenotype inclusive of angina (SOFT; n cases = 10,801) as well as a stricter definition without angina (HARD; n cases = 6,482) and selected cases with the former phenotype to conduct a meta-analysis using the two most recent CAD GWAS. This approach identified 13 new loci at genome-wide significance, 12 of which were on our previous list of loci meeting the 5% FDR threshold, thus providing strong support that the remaining loci identified by FDR represent genuine signals. The 304 independent variants associated at 5% FDR in this study explain 21.2% of CAD heritability and identify 243 loci that implicate pathways in blood vessel morphogenesis as well as lipid metabolism, nitric oxide signaling and inflammation.


  • Genetic and Molecular Epidemiology
  • EXODIAB: Excellence in Diabetes Research in Sweden
  • EpiHealth: Epidemiology for Health

Publishing year







Nature Genetics





Document type

Journal article


Nature Publishing Group


  • Medical Genetics
  • Cardiac and Cardiovascular Systems



Research group

  • Genetic and Molecular Epidemiology


  • ISSN: 1061-4036